Nrxs stock price.

View the latest Neuraxis Inc. (NRXS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Complete Neuraxis Inc. stock information by Barron's. View real-time NRXS stock price and news, along with industry-best analysis.Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Neuraxis Inc stocks price quote with latest real …(NYSEMKT: NRXS) Neuraxis stock price per share is $3.27 today (as of Dec 1, 2023). What is Neuraxis's Market Cap? ( NYSEMKT : NRXS ) Neuraxis 's market cap is …NRx Pharmaceuticals Inc stock price (NRXPW) NASDAQ: NRXPW. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert NRx Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.

Aug 15, 2023 · NeurAxis (NYSE-Amer: NRXS) stock is doing something many newly listed companies' shares aren't: trading higher. In fact, despite the bullish start by many in the past few months, short-selling investors have been feasting on recent IPOs, taking advantage of low outstanding share counts and even lower trading floats. NRXS's current price target is $0.00. Learn why top analysts are making this stock forecast for NeurAxis at MarketBeat.In addition, the Company has granted the underwriters a 45-day option to purchase up to 164,800 additional shares of common stock at the initial public offering price, less the underwriting discount.

52 Week Range 2.38 - 48.80. in 2020 the stock was $77. My price NRx Pharmaceuticals, Inc. (NRXP) has two Phase III assets for which it has Fast Track and Breakthrough Therapy designation, respectively: intravenous ZYESAMI® for Critical COVID-19 and NRX-101 for bipolar depression with suicidality. 52 Week Range 2.38 - 48.80. in 2020 the stock ...According to one analyst, the rating for NRXP stock is "Strong Buy" and the 12-month stock price forecast is $2.0. Price Target. $2.0 (466.57% upside)

Nov 30, 2023 · The average price predicted for NRX Pharmaceuticals Inc (NRXP) by analysts is $3.08, which is $2.73 above the current market price. The public float for NRXP is 56.08M, and at present, short sellers hold a 2.74% of that float. On November 30, 2023, the average trading volume of NRXP was 831.50K shares. NRXP) stock’s latest price update Find the latest The Boeing Company (BA) stock quote, history, news and other vital information to help you with your stock trading and investing.NRX Pharmaceuticals, Inc. (NASDAQ:NASDAQ:NRXP) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ETCompany ParticipantsMatthew Duffy - Chief...The NeurAxis, Inc. stock forecast for tomorrow is $ 2.52, which would represent a 6.47% gain compared to the current price. In the next week, the price of NRXS is expected to increase by 44.81% and hit $ 3.43. As far as the long-term NeurAxis, Inc. stock forecast is concerned, here’s what our ...Neuraxis Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... NRXS Stock Quotes API .

cb7eb8003f0df9a8867f4c0b9647bc7._hcMeli3YdHB70Peb8PpW7yyiCIbkBjWPeU3-Yr9vfI.pl8_MhDNDYiVuCKHF4aPIozh-RAj2leiX6oartqq86auUEUeFugzl7TfJA Advanced search

See the latest CNBX Pharmaceuticals Inc stock price (CNBX:PINX), related news, valuation, dividends and more to help you make your investing decisions.

CARMEL, Ind., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today reported financial results for the third quarter ended September 30, 2023.Highlights November 1 – acquired a 336,448 square foot industrial property located in London, Ontario for $55.8 million with $27.1 million of the purchase price being settled in units valued at $11.30 per unit.September 12 – increased the REIT’s unsecured credit facilities from $375 million to $525 million.July 4 – acquired a 141,534 sqFind the latest NeurAxis, Inc. (NRXS) stock quote, history, news and other vital information to help you with your stock trading and investing.The consensus price target of analysts on Wall Street is $3.08, which implies an increase of 87.99% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $5.25 respectively. As a result, NRXP is trading at a discount of -1318.92% off the target high and -440.54% off the low.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Dec 1, 2023 · See the latest NRX Pharmaceuticals Inc Ordinary Shares stock price (NRXP:XNAS), related news, valuation, dividends and more to help you make your investing decisions. See all brokers. View live Neuraxis, Inc. chart to track its stock's price action. Find market predictions, NRXS financials and market news.

NRXS NeurAxis, Inc.Stock Price & Overview. 94 followers. $3.22 0.06 ( +1.90%) 3:59 PM 12/01/23. NYSE | $USD | Post-Market: $3.27 +0.05 (+1.55%) 4:10 PM. Summary. Ratings.Stock analysis for Neuraxis Inc (NRXS:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.TipRanksDiscover historical prices for UPS stock on Yahoo Finance. View daily, weekly or monthly format back to when United Parcel Service, Inc. stock was issued.NRX has been acquired by HubHead Corp. , a private, cloud software company based in Toronto, led by Nigel Stokes, former DataMirror CEO and founder of MindAngler Capital. ... -January 21, 2014 at 06:02 am EST - MarketScreener

See the latest Neuraxis Inc stock price (NRXS:XASE), related news, valuation, dividends and more to help you make your investing decisions.

Page couldn't load • Instagram. Something went wrong. There's an issue and the page could not be loaded. Reload page.Find the latest NRx Pharmaceuticals, Inc. (NRXP) stock quote, history, news and other vital information to help you with your stock trading and investing.POCI Earnings Date and Information. Precision Optics last announced its earnings results on September 28th, 2023. The reported ($0.12) EPS for the quarter. The business had revenue of $5.02 million for the quarter. Precision Optics has generated ($0.06) earnings per share over the last year ( ($0.06) diluted earnings per share).In addition, the Company has granted the underwriters a 45-day option to purchase up to 164,800 additional shares of common stock at the initial public offering price, less the underwriting discount.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you …July 28, 2023. Four or more companies could list in the week ahead. While it is not an IPO, the week’s largest and most notable new listing comes from US-based appliance maker SharkNinja ( SN ). We could still see a notable deal or two launch, but time is running out before the IPO market’s annual “August break” in sizable offerings.View the latest Neuraxis Inc. (NRXS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Discover historical prices for AMC stock on Yahoo Finance. View daily, weekly or monthly format back to when AMC Entertainment Holdings, Inc. stock was issued.Current NRX Market CDN0.32 against Litchfield’s price target CDN4.00 per share. Litchfield Research Rationale • NRX met 2Q23 expectations. 2Q23 was in line with our estimate of a $0.02 EPS. loss • Closed on financing. On Sept 6, it closed a private placement, raising CAD$1,483,500.70. •. On Sept 13, the Company has completed a pre--

Nov 17, 2023 · Investing Quotes Stocks United States NRXS Overview Stock Screener Earnings Calendar Sectors | NRXS U.S.: NYSE American Neuraxis Inc. Watch list NEW Set a price target alert Closed Last...

Company profile page for Neuraxis Inc including stock price, company news, press releases, executives, board members, and contact information

NRXS | Complete Neuraxis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.CNBX Pharmaceuticals' stock was trading at $1.86 at the beginning of 2023. Since then, CNBX shares have decreased by 99.4% and is now trading at $0.0120. View the best growth stocks for 2023 here.It now plans to raise $17M by offering 3M shares at a price range of $5 to $6. The company had previously filed to offer the same number of shares at a range of $4 to $6.But by 2030, that figure is expected to reach as high as $800 billion, a forecast leading one analyst covering NRXS to say that its post-IPO value presents an opportunity "too compelling to ignore." Analyst Models For NRXS Share Price To Reach $14View Annual Reports. Ten years of annual and quarterly financial statements and annual report data for Neuraxis (NRXS). Income statements, balance sheets, cash flow statements and key ratios.View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.The NeurAxis, Inc. stock forecast for tomorrow is $ 2.52, which would represent a 6.47% gain compared to the current price. In the next week, the price of NRXS is expected to increase by 44.81% and hit $ 3.43. As far as the long-term NeurAxis, Inc. stock forecast is concerned, here’s what our ... 52 Week Range 2.38 - 48.80. in 2020 the stock was $77. My price NRx Pharmaceuticals, Inc. (NRXP) has two Phase III assets for which it has Fast Track and Breakthrough Therapy designation, respectively: intravenous ZYESAMI® for Critical COVID-19 and NRX-101 for bipolar depression with suicidality. 52 Week Range 2.38 - 48.80. in 2020 the stock ...10% least volatile stocks in AU Market. 3.1%. Stable Share Price: NRX is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 23% a week. Volatility Over Time: NRX's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of Australian stocks.

The average price predicted for NRX Pharmaceuticals Inc (NRXP) by analysts is $3.08, which is $2.73 above the current market price. The public float for NRXP is 56.08M, and at present, short sellers hold a 2.74% of that float. On November 30, 2023, the average trading volume of NRXP was 831.50K shares. NRXP) stock’s latest price updateGet the latest news on recent and upcoming IPOs (initial public offerings), pricing and filings for new issues, and today’s top-performing IPO stocks.Discover historical prices for NRXS stock on Yahoo Finance. View daily, weekly or monthly format back to when NeurAxis, Inc. stock was issued.Instagram:https://instagram. follat treestocks under dollar100corning company stockday trading firms NeurAxis ( NYSE: NRXS) said on Tuesday it had secured a $3M financing through a preferred stock offering priced at $2.38 per share. According to NRXS, the deal by affiliates of Inspire Health ... one month tbill raterealtymogul vs fundrise Nov 28, 2023 · The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.24% during the next 3 months and, with a 90% probability hold a price between $0.342 and $0.455 at the end of this 3-month period. new rtx cards Highlights November 1 – acquired a 336,448 square foot industrial property located in London, Ontario for $55.8 million with $27.1 million of the purchase price being settled in units valued at $11.30 per unit.September 12 – increased the REIT’s unsecured credit facilities from $375 million to $525 million.July 4 – acquired a 141,534 sq15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: NRXP is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week. Volatility Over Time: NRXP's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.